Matches in DBpedia 2014 for { <http://dbpedia.org/resource/GSK716155> ?p ?o. }
Showing items 1 to 15 of
15
with 100 items per page.
- GSK716155 abstract "GSK716155 (Albugon) is a recombinant human glucagon-like peptide (GLP)-1-Albumin protein created using Human Genome Sciences' proprietary albumin fusion technology, which involves fusing the gene that expresses human albumin to the gene that expresses a therapeutically active protein (GLP-1)[1]. It is an agonist of the Glucagon-like Peptide-1 Receptor (GLP1R) and underwent clinical drug trials for treatment of Type 2 Diabetes Mellitus. The fusing of therapeutic proteins to human albumin decreases clearance and prolongs the half-life of therapeutically active proteins in the body[1].".
- GSK716155 wikiPageExternalLink NCT00354536.
- GSK716155 wikiPageExternalLink index.html.
- GSK716155 wikiPageID "17380296".
- GSK716155 wikiPageRevisionID "596579489".
- GSK716155 hasPhotoCollection GSK716155.
- GSK716155 subject Category:Anti-diabetic_drugs.
- GSK716155 subject Category:Diabetes.
- GSK716155 comment "GSK716155 (Albugon) is a recombinant human glucagon-like peptide (GLP)-1-Albumin protein created using Human Genome Sciences' proprietary albumin fusion technology, which involves fusing the gene that expresses human albumin to the gene that expresses a therapeutically active protein (GLP-1)[1]. It is an agonist of the Glucagon-like Peptide-1 Receptor (GLP1R) and underwent clinical drug trials for treatment of Type 2 Diabetes Mellitus.".
- GSK716155 label "GSK716155".
- GSK716155 sameAs m.043p7px.
- GSK716155 sameAs Q5514567.
- GSK716155 sameAs Q5514567.
- GSK716155 wasDerivedFrom GSK716155?oldid=596579489.
- GSK716155 isPrimaryTopicOf GSK716155.